If you need more lookups,
subscriptions start at $34 USD/month.
Ivan Horak Location
Singapore
Ivan Horak Work
President of Research and Development @ (January 2019 - Present)
Chief Scientific and Medical Officer @ (April 2011 - Present)
CSO and CMO @ The Global Leaders (January 2011 - Present)
Chief Scientific Officer and President of Research and Development @ Eznon (February 2010 - April 2011)
CSO and president of R and D @ Enzon Pharmaceuticals (January 2005 - January 2011)
CSO @ Immunomedics (January 2002 - January 2005)
VP Clinical Oncology @ Pharmacia (January 1999 - January 2002)
Ivan Horak Education
Kommenius Medical School
MD (Medicine)
1969-1975
Ivan Horak Skills
Clinical Development
Translational medicine, Phase I - Phase III, from IND to NDA
Biotechnology
Oncology
Cancer
Clinical Trials
R&D
Drug Discovery
Lifesciences
Immunology
Drug Development
Pharmaceutical Industry
Technology Transfer
CRO
Infectious Diseases
Biopharmaceuticals
Pharmacology
Molecular Biology
Commercialization
Biochemistry
Regulatory Affairs
Cell
Protein Chemistry
GCP
Cell Biology
Assay Development
Vaccines
FDA
Cell Culture
ELISA
Regulatory Submissions
Microbiology
Biomarkers
Life Sciences
U.S. Food and Drug Administration (FDA)
From Ind to Nda
Phase Iii
Translational Medicine
Clinical Research
Marketing
Hospitals
u.s. Food and Drug Administration Fda
Research
u.s. Food and Drug Administration
Ivan Horak Summary
Ivan Horak, based in Singapore, is currently a President of Research and Development at Tessa Therapeutics Ltd. Ivan Horak brings experience from previous roles at Symphogen, The Global Leaders, Eznon and Enzon Pharmaceuticals. Ivan Horak holds a 1969 - 1975 MD in Medicine @ Kommenius Medical School. With a robust skill set that includes Clinical Development, Translational medicine, Phase I - Phase III, from IND to NDA, Biotechnology, Oncology, Cancer and more. Ivan Horak has 1 emails and 2 mobile phone numbers on RocketReach.
Looking for a different Ivan Horak?
Find contact details for 700 million professionals.